 |
|
Telling the Truth About Terminal Cancer
Thomas J. Smith, MD;
Karen Swisher, MS, JD
JAMA. 1998;279:1746-1748.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Cancer accounted for more than 23% of all deaths in 1997. Although much progress has been made in reducing cancer deaths, the inescapable truth is that most patients with recurrent cancers will die as a result of the malignancy. This is important for several reasons: (1) two thirds of all cancers are preventable,1 so much of the morbidity and mortality are unnecessary; (2) the cost of cancer care continues to increase, from $35 billion in 19902 to an estimated $50 billion in 19963; (3) some physicians and patients are probably not taking advantage of the progress made in treating metastatic cancer or its symptoms; and (4) far too many patients are fighting a battle they cannot win, and not taking advantage of good end-of-life care.
In this issue of JAMA, Weeks and colleagues4 delineate some reasons that patients fight cancer . . . [Full Text of this Article]
From the Division of Hematology/Oncology, the Massey Cancer Center, and Department of Internal Medicine (Dr Smith), and Legal Medicine and Health Administration (Dr Swisher), the School of Health Administration, Medical College of Virginia at Virginia Commonwealth University, Richmond.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTER
Communicating With Patients About Advanced Cancer
Maria F. Costantini-Ferrando, Kathleen M. Foley, Bruce D. Rapkin, B. J. Kennedy, Jane C. Weeks, and Thomas J. Smith
JAMA. 1998;280(16):1403-1404.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Relationship Between Cancer Patients' Predictions of Prognosis and Their Treatment Preferences
Jane C. Weeks, E. Francis Cook, Steven J. O'Day, Lynn M. Peterson, Neil Wenger, Douglas Reding, Frank E. Harrell, Peter Kussin, Neil V. Dawson, Alfred F. Connors, Jr, Joanne Lynn, and Russell S. Phillips
JAMA. 1998;279(21):1709-1714.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
What Are Terminally Ill Cancer Patients Told About Their Expected Deaths? A Study of Cancer Physicians' Self-Reports of Prognosis Disclosure
Daugherty and Hlubocky
JCO 2008;26:5988-5993.
ABSTRACT
| FULL TEXT
Why Do Patients Choose Chemotherapy Near the End of Life? A Review of the Perspective of Those Facing Death From Cancer
Matsuyama et al.
JCO 2006;24:3490-3496.
ABSTRACT
| FULL TEXT
Truth-Telling in Clinical Practice and the Arguments for and Against: a review of the literature
Tuckett
Nurs Ethics 2004;11:500-513.
ABSTRACT
The quality of medical care at the end-of-life in the USA: existing barriers and examples of process and outcome measures
Yabroff et al.
Palliat Med 2004;18:202-216.
ABSTRACT
The Attitudes of Cancer Patients and Their Families Toward the Disclosure of Terminal Illness
Yun et al.
JCO 2004;22:307-314.
ABSTRACT
| FULL TEXT
Tell It Like It Is
Smith
JCO 2003;21:12s-16.
FULL TEXT
A Staff Dialogue on Phase I Trials: Psychosocial Issues Faced by Patients, Their Families, and Caregivers
Lintz et al.
The Oncologist 2002;7:8-15.
ABSTRACT
| FULL TEXT
Preferences of Patients With Advanced Cancer for Hospice Care
Navari et al.
JAMA 2000;284:2449-2449.
FULL TEXT
Tell It Like It Is
Smith
JCO 2000;18:3441-3445.
FULL TEXT
Assessing the Generalizability of Prognostic Information
Justice et al.
ANN INTERN MED 1999;130:515-524.
ABSTRACT
| FULL TEXT
Communicating With Patients About Advanced Cancer
Costantini-Ferrando et al.
JAMA 1998;280:1403-1404.
FULL TEXT
|
